Glopec International Inc, based in Canada, is a pharmaceutical company.
One of their notable products is ACITRETIN, with a corresponding US DMF Number 26182.
Remarkably, this DMF maintains an Active status since its submission on July 11, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 13, 2015, and payment made on April 01, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II